4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-016192
Options or other derivatives
- Director acquired 20,543 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Mehra Anand Director | 2024-06-06 | Grant or award · Stock Option (Right to Buy) | +15,750 | 15,750 | D | ||
| Mehra Anand Director | 2024-06-06 | Grant or award · Restricted Stock Units | +4,793 | 4,793 | D | ||
Loading xslF345X05/form4-06102024_040602.xml…